This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
health care | 451 |
breast milk | 391 |
infection control | 341 |
respiratory syndrome | 282 |
acute respiratory | 256 |
airborne transmission | 252 |
infectious diseases | 230 |
severe acute | 229 |
infectious agents | 189 |
infectious disease | 182 |
public health | 171 |
hand hygiene | 157 |
healthcare workers | 151 |
united states | 137 |
human transmission | 132 |
staphylococcus aureus | 127 |
disease transmission | 127 |
transmission rate | 118 |
control measures | 117 |
risk factors | 117 |
intensive care | 116 |
care workers | 115 |
care settings | 113 |
syndrome coronavirus | 108 |
respiratory tract | 106 |
coronavirus disease | 101 |
standard precautions | 99 |
viral load | 94 |
novel coronavirus | 93 |
care facilities | 92 |
index case | 91 |
aerosol transmission | 90 |
disease control | 87 |
care unit | 86 |
virus transmission | 86 |
resistant staphylococcus | 86 |
direct contact | 86 |
influenza virus | 83 |
infection prevention | 80 |
transmission dynamics | 78 |
world health | 76 |
household transmission | 76 |
protective equipment | 74 |
personal protective | 73 |
transmission routes | 72 |
health organization | 71 |
infectious agent | 70 |
virus infection | 68 |
west nile | 67 |
respiratory viruses | 66 |
systematic review | 65 |
viral rna | 65 |
pathogen transmission | 65 |
symptom onset | 64 |
behavioral guidelines | 64 |
hong kong | 64 |
patient care | 63 |
control practices | 62 |
transmission via | 62 |
social distancing | 62 |
contact precautions | 61 |
expressed breast | 61 |
human milk | 60 |
middle east | 60 |
relative humidity | 59 |
infection risk | 59 |
east respiratory | 58 |
nile virus | 58 |
clinical signs | 56 |
incubation period | 55 |
generating procedures | 55 |
term care | 55 |
cord uid | 54 |
doc id | 54 |
may also | 54 |
vertical transmission | 53 |
yellow fever | 53 |
ebola virus | 53 |
immunodeficiency virus | 53 |
natural ventilation | 53 |
nosocomial transmission | 52 |
droplet nuclei | 52 |
surgical masks | 51 |
body fluids | 51 |
direct transmission | 50 |
droplet transmission | 50 |
based precautions | 50 |
infectious period | 50 |
human immunodeficiency | 50 |
transmission mitigation | 50 |
care facility | 49 |
mitigation behavioral | 49 |
healthcare settings | 49 |
herd immunity | 48 |
advisory committee | 48 |
increased risk | 48 |
prevent transmission | 48 |
contact tracing | 47 |
respiratory droplets | 46 |
close contact | 46 |
infected individuals | 45 |
infected person | 45 |
mucous membranes | 44 |
hiv transmission | 44 |
confirmed cases | 44 |
respiratory syncytial | 44 |
transmission risk | 44 |
transmission route | 43 |
virus type | 43 |
face masks | 43 |
secondary transmission | 42 |
ventilation systems | 42 |
respiratory infections | 42 |
susceptible host | 42 |
home care | 42 |
secondary cases | 42 |
respiratory secretions | 41 |
syncytial virus | 41 |
neonatal intensive | 41 |
via breast | 40 |
environmental contamination | 40 |
person transmission | 40 |
indoor air | 39 |
preventing transmission | 39 |
surgical mask | 39 |
nosocomial infections | 39 |
per hour | 39 |
community transmission | 38 |
infection cases | 38 |
environmental transmission | 38 |
indirect contact | 38 |
environmental factors | 37 |
droplet precautions | 37 |
hemorrhagic fever | 37 |
airborne route | 37 |
pregnant women | 37 |
premature infants | 37 |
infected patients | 37 |
medical masks | 37 |
author funder | 36 |
cystic fibrosis | 36 |
granted medrxiv | 36 |
oral transmission | 35 |
pandemic influenza | 35 |
clostridium difficile | 35 |
control strategies | 35 |
high risk | 35 |
breastfed infants | 35 |
transmission occurs | 35 |
population density | 34 |
disease ecology | 34 |
isolation precautions | 34 |
primary case | 34 |
tracheal intubation | 34 |
cohort study | 34 |
upper respiratory | 33 |
made available | 33 |
respiratory protection | 33 |
care units | 33 |
acute care | 33 |
severe disease | 33 |
immune response | 33 |
child transmission | 33 |
mycobacterium tuberculosis | 33 |
air samples | 32 |
differential diagnosis | 32 |
potentially infectious | 32 |
mouth disease | 32 |
close contacts | 32 |
reproduction number | 31 |
universal precautions | 31 |
exit strategies | 31 |
sars coronavirus | 31 |
avian influenza | 31 |
organ systems | 31 |
mobility data | 31 |
hiv infection | 31 |
transmission events | 31 |
healthcare facilities | 30 |
risk factor | 30 |
breast cancer | 30 |
sexually transmitted | 30 |
global health | 30 |
susceptible individuals | 30 |
personality traits | 30 |
family members | 30 |
infection rates | 30 |
eye protection | 29 |
zoster virus | 29 |
copyright holder | 29 |
airborne infection | 29 |
international license | 29 |
pseudomonas aeruginosa | 29 |
sars outbreak | 29 |
disease spread | 29 |
face mask | 29 |
reproductive number | 29 |
airborne precautions | 29 |
particle size | 29 |
infection transmission | 28 |
genomic data | 28 |
virus infections | 28 |
airborne particles | 28 |
version posted | 28 |
posted october | 28 |
less likely | 28 |
necropsy findings | 28 |
relative risk | 28 |
contact rates | 27 |
transmission among | 27 |
transmission within | 27 |
influenza viruses | 27 |
contact transmission | 27 |
fever virus | 27 |
ventilation system | 27 |
viral shedding | 27 |
air quality | 27 |
environmental conditions | 27 |
hand washing | 27 |
fed infants | 27 |
host species | 27 |
healthcare worker | 26 |
particulate respirators | 26 |
resistant enterococci | 26 |
bayesian inference | 26 |
sars transmission | 26 |
household members | 26 |
transmission may | 25 |
control programs | 25 |
fresh air | 25 |
fluid dynamics | 25 |
patient safety | 25 |
transmission potential | 25 |
one study | 25 |
bloodstream infections | 25 |
via breastfeeding | 25 |
respiratory illness | 25 |
another study | 25 |
nosocomial infection | 25 |
face shields | 25 |
mathematical models | 25 |
hospitalized patients | 25 |
disease dynamics | 25 |
lyme disease | 25 |
attack rate | 25 |
organ system | 25 |
practices advisory | 25 |
index cases | 24 |
engineering controls | 24 |
dengue virus | 24 |
transmission modes | 24 |
african countries | 24 |
antimicrobial resistance | 24 |
research complications | 24 |
virus disease | 24 |
exhaled breath | 24 |
environmental surfaces | 24 |
susceptible hosts | 23 |
case data | 23 |
epidemiological data | 23 |
immunization practices | 23 |
escherichia coli | 23 |
spreading events | 23 |
host population | 23 |
secondary attack | 23 |
oral route | 23 |
zika virus | 23 |
zoonotic spillover | 23 |
zoonotic pathogens | 23 |
recovery rate | 23 |
fatality rate | 22 |
nursing homes | 22 |
disease outbreaks | 22 |
tracer gas | 22 |
case numbers | 22 |
hygiene practices | 22 |
respiratory infection | 22 |
indoor environments | 22 |
borne transmission | 22 |
large droplets | 22 |
size distribution | 22 |
cough etiquette | 22 |
ventilation rate | 22 |
care personnel | 22 |
among health | 22 |
household contacts | 22 |
microbiology laboratory | 22 |
west africa | 22 |
viral respiratory | 22 |
pediatric patients | 22 |
general population | 22 |
total incidence | 22 |
may occur | 21 |
air conditioning | 21 |
cluster sizes | 21 |
inanimate surfaces | 21 |
sexual transmission | 21 |
immune system | 21 |
air flow | 21 |
host cell | 21 |
attack rates | 21 |
heat recovery | 21 |
respiratory virus | 21 |
transmission rates | 21 |
sars patients | 21 |
commonly used | 21 |
risk assessment | 21 |
disease virus | 21 |
control study | 21 |
transmitted via | 21 |
nosocomial outbreak | 21 |
infections among | 20 |
air changes | 20 |
cov transmission | 20 |
care setting | 20 |
chain reaction | 20 |
nursing home | 20 |
clinical microbiology | 20 |
virus environmental | 20 |
recent study | 20 |
different types | 20 |
antimicrobial agents | 20 |
patient rooms | 20 |
virus host | 20 |
airborne infectious | 20 |
emerging infectious | 20 |
smallpox vaccination | 20 |
risk groups | 20 |
reducing human | 20 |
future research | 19 |
mask use | 19 |
high school | 19 |
internal organ | 19 |
important role | 19 |
risk group | 19 |
among humans | 19 |
viral transmission | 19 |
chronic diseases | 19 |
least one | 19 |
immunocompromised patients | 19 |
egg production | 19 |
respiratory diseases | 19 |
evidence indicates | 19 |
general public | 19 |
prospective study | 19 |
respiratory disease | 19 |
bacterial contamination | 19 |
care worker | 19 |
newcastle disease | 19 |
healthcare personnel | 19 |
superspreading events | 19 |
epidemic models | 19 |
virus survival | 19 |
among healthcare | 19 |
confirmed covid | 19 |
diseases society | 18 |
prolonged periods | 18 |
transmission function | 18 |
exclusive breastfeeding | 18 |
infectious virus | 18 |
see appendix | 18 |
peer review | 18 |
time series | 18 |
bloodborne pathogens | 18 |
resistant organisms | 18 |
polymerase chain | 18 |
nonintact skin | 18 |
clinical characteristics | 18 |
care providers | 18 |
care hospitals | 18 |
different countries | 18 |
infection via | 18 |
negative pressure | 18 |
removal rate | 18 |
big five | 18 |
donor pigs | 18 |
ecology theory | 18 |
compartmental models | 18 |
case fatality | 18 |
antimicrobial stewardship | 18 |
large numbers | 18 |
asymptomatic carriers | 17 |
cardiopulmonary resuscitation | 17 |
tract infections | 17 |
viral disease | 17 |
internal organs | 17 |
viral loads | 17 |
protection equipment | 17 |
modelling study | 17 |
higher risk | 17 |
control interventions | 17 |
biodiversity loss | 17 |
protective effect | 17 |
also may | 17 |
outbreak data | 17 |
hospital setting | 17 |
computational fluid | 17 |
time period | 17 |
median age | 17 |
surface contamination | 17 |
contact route | 17 |
young children | 17 |
preventive measures | 17 |
virus particles | 17 |
copies per | 17 |
data collection | 17 |
hospital settings | 17 |
viral infections | 17 |
may help | 17 |
persistence time | 17 |
isolation rooms | 17 |
respiratory hygiene | 17 |
remain suspended | 17 |
control precautions | 17 |
disease risk | 16 |
antibiotic resistance | 16 |
virus shedding | 16 |
cmv infection | 16 |
infectious dose | 16 |
infected persons | 16 |
cov infection | 16 |
long distances | 16 |
communicable diseases | 16 |
several studies | 16 |
source control | 16 |
home environment | 16 |
incidence rate | 16 |
face shield | 16 |
following exposure | 16 |
one case | 16 |
gastrointestinal tract | 16 |
infection occurs | 16 |
air sampling | 16 |
central venous | 16 |
hcv rna | 16 |
viable virus | 16 |
isolation room | 16 |
susceptible individual | 16 |
maternal infection | 16 |
transmission risks | 16 |
democratic republic | 16 |
infectious material | 16 |
disease outbreak | 16 |
fomite transmission | 16 |
virus genome | 16 |
aerosol generation | 16 |
family cluster | 16 |
latent period | 16 |
positive mothers | 16 |
patient room | 16 |
healthcare infection | 16 |
iu lb | 16 |
jakob disease | 16 |
preterm infants | 16 |
sars among | 16 |
virus infiltration | 16 |
environmental survival | 16 |
human populations | 16 |
children younger | 16 |
patient transmission | 16 |
infants born | 16 |
mechanical ventilation | 16 |
negative bacilli | 16 |
transmitted pathogens | 15 |
body infiltration | 15 |
infection among | 15 |
even though | 15 |
transmission mechanism | 15 |
healthcare epidemiology | 15 |
congenital infection | 15 |
personal hygiene | 15 |
coronavirus infection | 15 |
air distribution | 15 |
medical procedures | 15 |
remain airborne | 15 |
real time | 15 |
time lag | 15 |
germicidal irradiation | 15 |
infectious particles | 15 |
working group | 15 |
theoretical concepts | 15 |
will also | 15 |
high viral | 15 |
anesthesia providers | 15 |
case reports | 15 |
significantly higher | 15 |
ultraviolet germicidal | 15 |
acquired infections | 15 |
antiretroviral therapy | 15 |
displacement ventilation | 15 |
targeted control | 15 |
infection period | 15 |
female fraction | 15 |
borne pathogens | 15 |
total number | 15 |
study group | 15 |
infectious individuals | 15 |
hygiene cough | 15 |
positive test | 15 |
new cases | 15 |
clinical trials | 15 |
network inference | 15 |
transmission trees | 15 |
potential risk | 15 |
air travel | 15 |
available data | 15 |
transmission models | 15 |
relative importance | 15 |
tested positive | 15 |
stale air | 15 |
cluster size | 14 |
disease systems | 14 |
operating room | 14 |
host density | 14 |
become infected | 14 |
blood products | 14 |
basic reproduction | 14 |
infected patient | 14 |
virus adsorption | 14 |
cfd simulation | 14 |
individual variation | 14 |
via droplets | 14 |
molecular epidemiology | 14 |
supplementary table | 14 |
droplet route | 14 |
cause disease | 14 |
injection practices | 14 |
patient contact | 14 |
influenza transmission | 14 |
occupancy buildings | 14 |
tohuman transmission | 14 |
com scientificreports | 14 |
cell culture | 14 |
virus may | 14 |
tract infection | 14 |
many cases | 14 |
hiv aids | 14 |
incubation phase | 14 |
reduce transmission | 14 |
cov outbreak | 14 |
confirmed case | 14 |
infected individual | 14 |
infants younger | 14 |
body fluid | 14 |
wide range | 14 |
clinical features | 14 |
cruise ship | 14 |
high mortality | 14 |
transmission patterns | 14 |
medrxiv preprint | 14 |
larger droplets | 14 |
risk settings | 14 |
contaminated surfaces | 14 |
intervention strategies | 14 |
infections associated | 14 |
case studies | 14 |
mucous membrane | 14 |
changes per | 14 |
high occupancy | 14 |
infections transmitted | 14 |
evidence suggests | 14 |
clinically significant | 14 |
south korea | 14 |
large number | 14 |
data sources | 14 |
control efforts | 14 |
environmental cleaning | 14 |
primary cases | 14 |
room air | 14 |
lassa fever | 14 |
scientific evidence | 14 |
indirect transmission | 14 |
human host | 13 |
epidemiologically important | 13 |
flow rate | 13 |
will help | 13 |
physical distancing | 13 |
cell leukemia | 13 |
viruses belonging | 13 |
respiratory viral | 13 |
human population | 13 |
clinical disease | 13 |
high level | 13 |
lymphotropic virus | 13 |
cytomegalovirus infection | 13 |
subclinical infectiousness | 13 |
stainless steel | 13 |
care delivery | 13 |
new infection | 13 |
missing data | 13 |
sir model | 13 |
sodium hypochlorite | 13 |
critical care | 13 |
cases per | 13 |
glove use | 13 |
common cold | 13 |
enveloped viruses | 13 |
small number | 13 |
host tropism | 13 |
mortality rate | 13 |
transmission tree | 13 |
bloodstream infection | 13 |
ebola outbreak | 13 |
united kingdom | 13 |
among patients | 13 |
many countries | 13 |
nucleic acid | 13 |
ventilation strategies | 13 |
symptomatic patient | 13 |
retrospective cohort | 13 |
main transmission | 13 |
spillover transmission | 13 |
disease emergence | 13 |
reducing spillover | 13 |
natural history | 13 |
patients infected | 13 |
physical contact | 13 |
medical care | 13 |
influenza pandemic | 13 |
postexposure prophylaxis | 13 |
lattice boltzmann | 13 |
transmission hazard | 13 |
outbreak response | 13 |
rights reserved | 13 |
medical students | 13 |
infected mothers | 13 |
four virus | 13 |
adverse events | 13 |
may vary | 13 |
milk samples | 13 |
occupational health | 13 |
reported cases | 13 |
hospital infection | 13 |
herpes simplex | 13 |
lower respiratory | 13 |
barrier precautions | 13 |
standard deviation | 13 |
new york | 13 |
life cycle | 13 |
effective control | 13 |
observational studies | 13 |
dependent transmission | 13 |
infectious periods | 13 |
viral diseases | 12 |
infectious aerosols | 12 |
see table | 12 |
acquired immunity | 12 |
ebv infection | 12 |
stem cell | 12 |
infant transmission | 12 |
greater risk | 12 |
outdoor air | 12 |
natural selection | 12 |
time interval | 12 |
logistic regression | 12 |
familial cluster | 12 |
range airborne | 12 |
within hours | 12 |
infectious pathogens | 12 |
recent years | 12 |
family size | 12 |
associated diarrhea | 12 |
flight transmission | 12 |
disease caused | 12 |
transmission heterogeneity | 12 |
associated infections | 12 |
bone marrow | 12 |
long periods | 12 |
mixing model | 12 |
may increase | 12 |
epidemic dynamics | 12 |
experimental study | 12 |
safe injection | 12 |
medical equipment | 12 |
age group | 12 |
birth weight | 12 |
index patient | 12 |
transmission network | 12 |
safety culture | 12 |
nurse staffing | 12 |
extended periods | 12 |
american academy | 12 |
indoor airflow | 12 |
within families | 12 |
may include | 12 |
cfd method | 12 |
transfer efficiency | 12 |
clinical symptoms | 12 |
aureus infection | 12 |
measles virus | 12 |
control policies | 12 |
rna viruses | 12 |
possible transmission | 12 |
infection associated | 12 |
human infection | 12 |
staff members | 12 |
contaminated hands | 12 |
secondary infections | 12 |
airborne spread | 12 |
positive women | 12 |
ambulatory care | 12 |
official publication | 12 |
factors associated | 12 |
hospital rooms | 12 |
coronavirus infections | 12 |
antimicrobial prophylaxis | 12 |
mobility patterns | 12 |
cases among | 12 |
influenza vaccination | 12 |
fmd outbreak | 12 |
survival rate | 12 |
absolute humidity | 12 |
epidemiological models | 12 |
ttv dna | 12 |
epithelial cells | 12 |
drinking water | 12 |
van der | 12 |
aspergillus spp | 11 |
south africa | 11 |
disease management | 11 |
seropositive mothers | 11 |
much less | 11 |
two groups | 11 |
diamond princess | 11 |
persistent infections | 11 |
surface stability | 11 |
skilled nursing | 11 |
bmj global | 11 |
transmission amplifiers | 11 |
economic family | 11 |
published studies | 11 |
control program | 11 |
contact networks | 11 |
respiratory pathogens | 11 |
emerging pathogens | 11 |
leukemia virus | 11 |
close proximity | 11 |
data provided | 11 |
human respiratory | 11 |
vast majority | 11 |
closely related | 11 |
human breast | 11 |
hospital outbreak | 11 |
current normal | 11 |
epidemic spread | 11 |
barr virus | 11 |
surgical hand | 11 |
infected people | 11 |
will prevent | 11 |
mucosal surfaces | 11 |
may reduce | 11 |
better understand | 11 |
home health | 11 |
air temperature | 11 |
airborne pathogens | 11 |
viral particles | 11 |
distancing measures | 11 |
appropriate use | 11 |
ambulatory settings | 11 |
fmdv rna | 11 |
ncov infection | 11 |
markov chain | 11 |
health service | 11 |
surveillance data | 11 |
mortality rates | 11 |
respiratory symptoms | 11 |
network models | 11 |
hcv infection | 11 |
based hand | 11 |
aerosol particles | 11 |
milk transmission | 11 |
asymptomatic cases | 11 |
low level | 11 |
determine whether | 11 |
coronavirus outbreak | 11 |
active cases | 11 |
model parameters | 11 |
body fashion | 11 |
disease associated | 11 |
community outbreak | 11 |
pathogen genomic | 11 |
small particles | 11 |
primary infection | 11 |
authors declare | 11 |
first months | 11 |
tcid ml | 11 |
prevention measures | 11 |
spillover reduction | 11 |
controlled trial | 11 |
elementary school | 11 |
journal rspb | 11 |
fever vaccine | 11 |
healthy individuals | 11 |
endotracheal intubation | 11 |
laden aerosols | 11 |
infection rate | 11 |
surgical procedures | 11 |
direct patient | 11 |
occurs via | 11 |
viral hemorrhagic | 11 |
clinical trial | 11 |
transmission parameters | 11 |
clinical specimens | 11 |
free equilibrium | 11 |
reproduction numbers | 11 |
risk estimates | 11 |
single patient | 11 |
symptomatic patients | 11 |
prevention strategies | 11 |
health authorities | 11 |
among children | 11 |
low risk | 11 |
inference methods | 11 |
mathematical model | 11 |
higher proportion | 11 |
competing interests | 11 |
experimental studies | 11 |
resistant enterococcus | 11 |
crossroads hotel | 11 |
indoor environment | 10 |
research purposes | 10 |
proxy measures | 10 |
acquired mrsa | 10 |
occupied spaces | 10 |
management outcomes | 10 |
mathematical modelling | 10 |
confirmed sars | 10 |
clinical infectious | 10 |
subclinical infectious | 10 |
american society | 10 |
contact groups | 10 |
new pathogens | 10 |
large droplet | 10 |
air sacculitis | 10 |
human herpes | 10 |
adenovirus type | 10 |
hand contamination | 10 |
wash hands | 10 |
significant role | 10 |
emergency department | 10 |
hbv infection | 10 |
mask worn | 10 |
transmission clusters | 10 |
doctor shopping | 10 |
average number | 10 |
recently published | 10 |
gene therapy | 10 |
transmission occurred | 10 |
room temperature | 10 |
gbs disease | 10 |
temporal dynamics | 10 |
air exchange | 10 |
income countries | 10 |
environmental sources | 10 |
sierra leone | 10 |
spreading event | 10 |
scientific community | 10 |
birth canal | 10 |
vary widely | 10 |
health services | 10 |
randomized clinical | 10 |
pulmonary tuberculosis | 10 |
highly contagious | 10 |
passively acquired | 10 |
severity level | 10 |
outbreak size | 10 |
princess cruise | 10 |
transmission term | 10 |
org journal | 10 |
associated bloodstream | 10 |
transmission model | 10 |
hospital workers | 10 |
infection prevalence | 10 |
type ii | 10 |
health workers | 10 |
convolutional lstm | 10 |
basic reproductive | 10 |
serial interval | 10 |
microbial contamination | 10 |
infection isolation | 10 |
different transmission | 10 |
virus causing | 10 |
disease surveillance | 10 |
ventilation rates | 10 |
transmission pathways | 10 |
occupational safety | 10 |
interim guidance | 10 |
outpatient settings | 10 |
large outbreaks | 10 |
population level | 10 |
asymptomatic transmission | 10 |
invasive disease | 10 |
elective peri | 10 |
air flows | 10 |
case i | 10 |
infection severity | 10 |
virus spread | 10 |
using cfd | 10 |
medical staff | 10 |
wild birds | 10 |
viral copies | 10 |
population size | 10 |
virus families | 10 |
air handling | 10 |
chikungunya virus | 10 |
equipment contamination | 10 |
experimental conditions | 10 |
burn unit | 10 |
among household | 10 |
air currents | 10 |
per day | 10 |
may become | 10 |
ct values | 10 |
indoor airborne | 10 |
first step | 10 |
pseudomonas cepacia | 10 |
transplant recipients | 10 |
surface environmental | 10 |
care hospital | 10 |
skin lesions | 10 |
infectious individual | 10 |
emotional stability | 10 |
body environment | 10 |
cases infected | 10 |
aedes aegypti | 10 |
spatial distribution | 10 |
i infection | 10 |
causing covid | 10 |
high levels | 10 |
infection preventionists | 10 |
different environmental | 10 |
hematopoietic stem | 10 |
per ml | 10 |
may result | 10 |
disease prevention | 10 |
surveillance system | 10 |
persons per | 10 |
spread via | 10 |
airborne virus | 10 |
fomite route | 10 |
new host | 10 |
resource investment | 10 |
probability distribution | 10 |
differential equations | 10 |
rspb proc | 10 |
dental practice | 10 |
also found | 10 |
health interventions | 10 |
sexual contact | 10 |
poorly ventilated | 10 |
postnatal infection | 10 |
routine patient | 10 |
study showed | 10 |
virus inactivation | 10 |
infected pneumonia | 10 |
individuals may | 10 |
infectious patients | 10 |
negative bacteria | 10 |
mg lb | 10 |
respiratory droplet | 10 |
students exposed | 10 |
may provide | 10 |
national institute | 9 |
widely used | 9 |
species transmission | 9 |
saharan africa | 9 |
air pollution | 9 |
epidemiological parameters | 9 |
may need | 9 |
virus via | 9 |
social network | 9 |
via respiratory | 9 |
isolation gowns | 9 |
transmission approximation | 9 |
may contribute | 9 |
geographic spread | 9 |
fit testing | 9 |
infiltration score | 9 |
low birth | 9 |
cesarean delivery | 9 |
incubation periods | 9 |
airborne droplets | 9 |
infectious bursal | 9 |
times higher | 9 |
years old | 9 |
influence transmission | 9 |
rna load | 9 |
hospital wards | 9 |
preventable diseases | 9 |
disease incidence | 9 |
quality control | 9 |
door handles | 9 |
confined spaces | 9 |
syndrome virus | 9 |
wound infections | 9 |
seasonal influenza | 9 |
local transmission | 9 |
cedar meats | 9 |
infection surveillance | 9 |
animal models | 9 |
infected animals | 9 |
became infected | 9 |
nonlinear incidence | 9 |
may lead | 9 |
respiratory transmission | 9 |
fecal contamination | 9 |
epidemic growth | 9 |
knowledge gaps | 9 |
borne diseases | 9 |
bursal disease | 9 |
vaccination program | 9 |
wearing gloves | 9 |
routine use | 9 |
odds ratio | 9 |
dengue transmission | 9 |
breast feeding | 9 |
virus organ | 9 |
saudi arabia | 9 |
social media | 9 |
part i | 9 |
continued breastfeeding | 9 |
subcritical zoonoses | 9 |
case study | 9 |
ambient temperature | 9 |
per room | 9 |
resource levels | 9 |
communicable infection | 9 |
van doremalen | 9 |
elusive pathway | 9 |
numerical simulations | 9 |
ring vaccination | 9 |
human mobility | 9 |
high rates | 9 |
testing delays | 9 |
site infections | 9 |
host abundance | 9 |
weather features | 9 |
asymptomatic sars | 9 |
chemical disinfection | 9 |
subcritical pathogens | 9 |
forecasting system | 9 |
prenatal infection | 9 |
private households | 9 |
potential transmission | 9 |
virus infectivity | 9 |
health department | 9 |
influenza vaccine | 9 |
ebola epidemic | 9 |
built environment | 9 |
innate immune | 9 |
potential source | 9 |
compartmental model | 9 |
results indicate | 9 |
drag coefficient | 9 |
human pathogens | 9 |
empiric therapy | 9 |
clinical practice | 9 |
respiratory failure | 9 |
herpes virus | 9 |
transmission will | 9 |
wildlife disease | 9 |
clinical illness | 9 |
prone acute | 9 |
factors affecting | 9 |
mixing coefficient | 9 |
sustained human | 9 |
environmental infection | 9 |
cov virus | 9 |
total infection | 9 |
sensitivity analyses | 9 |
including sars | 9 |
less frequently | 9 |
isolation wards | 9 |
total infectious | 9 |
simulation results | 9 |
amoy gardens | 9 |
der waals | 9 |
active infection | 9 |
term infants | 9 |
posterior probability | 9 |
vaccine virus | 9 |
rotavirus infection | 9 |
corona virus | 9 |
breastfeeding mother | 9 |
transmission scenario | 9 |
transmit via | 9 |
also include | 9 |
environmental samples | 9 |
dental care | 9 |
lactating women | 9 |
smallpox vaccine | 9 |
patients undergoing | 9 |
different levels | 9 |
chronic care | 9 |
epidemiological studies | 9 |
type i | 9 |
th century | 9 |
sars cov | 9 |
study found | 9 |
based models | 9 |
pediatric hospital | 9 |
see http | 9 |
sars patient | 9 |
contact patterns | 9 |
within rows | 9 |
care provider | 9 |
healthcare setting | 9 |
epidemic model | 9 |
national nosocomial | 9 |
asymptomatic individuals | 9 |
virus rna | 9 |
recommended infection | 9 |
via aerosols | 9 |
postnatal transmission | 9 |
species diversity | 9 |
expected number | 9 |
amino acids | 9 |
body substance | 9 |
inhalable aerosols | 9 |
fever viruses | 9 |
laboratory studies | 9 |
related viruses | 9 |
control guidelines | 8 |
enteric pathogens | 8 |
chronic disease | 8 |
higher viral | 8 |
significantly lower | 8 |
precautions include | 8 |
cell transplantation | 8 |
viruses may | 8 |
health systems | 8 |
social networks | 8 |
alimentary tract | 8 |
susceptible persons | 8 |
nasal mucosa | 8 |
hai rates | 8 |
diagnostic tests | 8 |
potentially contaminated | 8 |
asymptomatic infection | 8 |
virus transfer | 8 |
burn wound | 8 |
isolation guidelines | 8 |
acute infectious | 8 |
transmission chain | 8 |
nursing staff | 8 |
simulated sunlight | 8 |
human cases | 8 |
wuhan hospitals | 8 |
highly infectious | 8 |
cumulative infection | 8 |
may cause | 8 |
south america | 8 |
rabies virus | 8 |
first wave | 8 |
recent outbreak | 8 |
continuing breastfeeding | 8 |
room ultraviolet | 8 |
secretory iga | 8 |
risk associated | 8 |
will usually | 8 |
severe respiratory | 8 |
among medical | 8 |
drug administration | 8 |
lessons learned | 8 |
choir practice | 8 |
data used | 8 |
urban areas | 8 |
possible routes | 8 |
public reporting | 8 |
unsteady flow | 8 |
confidence interval | 8 |
transmission associated | 8 |
major role | 8 |
temporal changes | 8 |
substance isolation | 8 |
rna detection | 8 |
ill patients | 8 |
performed using | 8 |
epithelial modes | 8 |
poorly understood | 8 |
additional precautions | 8 |
one patient | 8 |
commercial airliner | 8 |
time required | 8 |
food preparation | 8 |
particularly high | 8 |
severe covid | 8 |
joint mission | 8 |
early stages | 8 |
high sars | 8 |
infected hosts | 8 |
intestinal tract | 8 |
critically ill | 8 |
artificial nails | 8 |
protecting health | 8 |
young adults | 8 |
controlled trials | 8 |
acinetobacter baumannii | 8 |
infections surveillance | 8 |
randomized trial | 8 |
influenza among | 8 |
computational times | 8 |
transmit infection | 8 |
antibiotic treatment | 8 |
clinical course | 8 |
crucial role | 8 |
acquired methicillin | 8 |
drug resistance | 8 |
occur via | 8 |
outpatient clinics | 8 |
child care | 8 |
collective strategies | 8 |
particles may | 8 |
new infections | 8 |
hydrogen peroxide | 8 |
precautions may | 8 |
airflow patterns | 8 |
large proportion | 8 |
large outbreak | 8 |
endemic areas | 8 |
avian encephalomyelitis | 8 |
remain infectious | 8 |
vector control | 8 |
based forecasting | 8 |
free survival | 8 |
immunity threshold | 8 |
ipc precaution | 8 |
extremely low | 8 |
infection risks | 8 |
respiratory particles | 8 |
occupational exposure | 8 |
infected host | 8 |
multiple persons | 8 |
contact rate | 8 |
nervous system | 8 |
young chicks | 8 |
per unit | 8 |
containing droplets | 8 |
respirable aerosols | 8 |
may play | 8 |
infection caused | 8 |
clinical outcomes | 8 |
management strategies | 8 |
range transmission | 8 |
venous catheters | 8 |
disease severity | 8 |
comparative study | 8 |
prediction period | 8 |
cruise ships | 8 |
coronavirus indicating | 8 |
infectious causation | 8 |
generation cephalosporins | 8 |
north america | 8 |
will reduce | 8 |
nosocomial pathogens | 8 |
risk patients | 8 |
epidemiologic studies | 8 |
based handrub | 8 |
host range | 8 |
children born | 8 |
pressure ventilation | 8 |
outbreak associated | 8 |
shock syndrome | 8 |
single dose | 8 |
hbv vaccine | 8 |
nursing facility | 8 |
droplet size | 8 |
home hygiene | 8 |
parainfluenza virus | 8 |
i transmission | 8 |
breast lesions | 8 |
directly transmitted | 8 |
control procedures | 8 |
necrotizing enterocolitis | 8 |
resistant bacteria | 8 |
human influenza | 8 |
antimicrobial activity | 8 |
vaccinia virus | 8 |
generation cases | 8 |
surface disinfection | 8 |
epidemiological characteristics | 8 |
protective environment | 8 |
zoonotic event | 8 |
antimicrobial therapy | 8 |
reduce spillover | 8 |
total population | 8 |
statistically significant | 8 |
protective immunity | 8 |
precaution recommendations | 8 |
experimental data | 8 |
recommended precautions | 8 |
visibly soiled | 8 |
particle transport | 8 |
west african | 8 |
whole class | 8 |
patient outcomes | 8 |
risk reduction | 8 |
room ventilation | 8 |
different contexts | 8 |
better understanding | 8 |
tap water | 8 |
pregnant woman | 8 |
genome sequencing | 8 |
positive air | 8 |
transport phenomena | 8 |
generating procedure | 8 |
congenital malformations | 8 |
precautionary principle | 8 |
human coronavirus | 8 |
first reported | 8 |
wasting disease | 8 |
transmissible infectious | 8 |
long term | 8 |
clinical settings | 8 |
measles outbreak | 8 |
may require | 8 |
host factors | 8 |
ventilation strategy | 8 |
transmission characteristics | 8 |
enteric viruses | 8 |
nonpharmaceutical interventions | 8 |
airborne disease | 8 |
unit time | 8 |
viral cultures | 8 |
preventing influenza | 8 |
cord blood | 8 |
pediatric infectious | 8 |
lower levels | 8 |
infected children | 8 |
health policy | 8 |
many researchers | 8 |
infection cycle | 8 |
hand antisepsis | 8 |
portable air | 8 |
within households | 8 |
care centers | 8 |
symptomatic individuals | 8 |
creative commons | 8 |
air cleaners | 8 |
environmental settings | 8 |
clean air | 8 |
health system | 8 |
pharmaceutical interventions | 8 |
pneumonia associated | 8 |
may affect | 8 |
cell infection | 8 |
chronic wasting | 8 |
airborne particle | 8 |
first case | 8 |
particulate air | 8 |
human coronaviruses | 8 |
simplex virus | 8 |
data collected | 8 |
multimodal data | 8 |
healthcare providers | 8 |
causative agent | 8 |
supplementary material | 8 |
via contaminated | 8 |
rotavirus vaccines | 8 |
like viruses | 8 |
infants receiving | 8 |
observational study | 8 |
positive pressure | 8 |
see chapter | 8 |
epidemiological analysis | 8 |
virus outbreak | 8 |
among hospital | 8 |
systems may | 8 |
current investigation | 8 |
transmission ecology | 8 |
face contact | 8 |
ncov transmission | 8 |
like illness | 8 |
five personality | 8 |
one host | 8 |
one health | 8 |
aerosol generating | 8 |
disease may | 7 |
relative infectivity | 7 |
spectrum beta | 7 |
infectious transmission | 7 |
see section | 7 |
well described | 7 |
electronic supplementary | 7 |
transmission networks | 7 |
infections caused | 7 |
droplets generated | 7 |
environmental drivers | 7 |
sars outbreaks | 7 |
becoming infected | 7 |
airborne viral | 7 |
spillover rates | 7 |
acquired antibodies | 7 |
onset date | 7 |
tuberculosis outbreak | 7 |
studies suggest | 7 |
early detection | 7 |
available evidence | 7 |
environmental reservoir | 7 |
many studies | 7 |
rhinovirus colds | 7 |
smaller particles | 7 |
hantavirus pulmonary | 7 |
low levels | 7 |
densely populated | 7 |
systematic reviews | 7 |
new data | 7 |
spillover rate | 7 |
infiltration scores | 7 |
confidence intervals | 7 |
pcr testing | 7 |
safely managed | 7 |
control practice | 7 |
brownian motion | 7 |
health status | 7 |
test results | 7 |
significant difference | 7 |
far droplets | 7 |
older adults | 7 |
literature review | 7 |
infections acquired | 7 |
streptococcal disease | 7 |
monte carlo | 7 |
also used | 7 |
transmammary transmission | 7 |
potential pathogens | 7 |
mrsa infection | 7 |
get infected | 7 |
reason exists | 7 |
spillover risk | 7 |
equine viruses | 7 |
pediatric intensive | 7 |
respiratory activities | 7 |
susceptible population | 7 |
higher rates | 7 |
will occur | 7 |
vaccine uptake | 7 |
evidence base | 7 |
patient populations | 7 |
poor ventilation | 7 |
gross lesions | 7 |
pulmonary syndrome | 7 |
elementary schools | 7 |
coronavirus transmission | 7 |
outbreak investigations | 7 |
respiratory specimens | 7 |
reynolds number | 7 |
ipc program | 7 |
outside air | 7 |
disease occurs | 7 |
droplet contact | 7 |
first days | 7 |
major cause | 7 |
infusion therapy | 7 |
must also | 7 |
second wave | 7 |
current pandemic | 7 |
first order | 7 |
nosocomial respiratory | 7 |
specific disease | 7 |
control activities | 7 |
studies show | 7 |
infected pigs | 7 |
high population | 7 |
influenza season | 7 |
virus remains | 7 |
global burden | 7 |
air recirculation | 7 |
case counts | 7 |
pediatric oncology | 7 |
rhinovirus infections | 7 |
cfd methods | 7 |
workers exposed | 7 |
phylogenetic tree | 7 |
current knowledge | 7 |
suspension time | 7 |
resistant gram | 7 |
respiratory pathogen | 7 |
lesser extent | 7 |
burn patients | 7 |
relative contributions | 7 |
reactive strategy | 7 |
hygiene compliance | 7 |
persons exposed | 7 |
laden droplets | 7 |
communicable disease | 7 |
tree reconstruction | 7 |
prevent contact | 7 |
system involvement | 7 |
recent outbreaks | 7 |
antibiotic therapy | 7 |
primary transmission | 7 |
tissue culture | 7 |
clinical manifestations | 7 |
several different | 7 |
one report | 7 |
previous studies | 7 |
effective therapy | 7 |
virus strains | 7 |
reducing transmission | 7 |
aircraft cabins | 7 |
aureus infections | 7 |
daily cases | 7 |
will confirm | 7 |
epidemiologic data | 7 |
specific infectious | 7 |
diarrheal diseases | 7 |
health agencies | 7 |
falling curve | 7 |
via contact | 7 |
reverse transcriptase | 7 |
external features | 7 |
human disease | 7 |
system tropism | 7 |
pressure isolation | 7 |
immune globulin | 7 |
hav infection | 7 |
notification data | 7 |
different settings | 7 |
air sacs | 7 |
via direct | 7 |
respirators used | 7 |
soft tissue | 7 |
supporting information | 7 |
patients may | 7 |
address matching | 7 |
immune responses | 7 |
infected farms | 7 |
case notification | 7 |
human beings | 7 |
gestational age | 7 |
germ theory | 7 |
windows closed | 7 |
sharps injuries | 7 |
different control | 7 |
particle sizes | 7 |
reservoir hosts | 7 |
infant pairs | 7 |
general ward | 7 |
care system | 7 |
surrounding environment | 7 |
human movement | 7 |
hemorrhagic fevers | 7 |
computational burden | 7 |
urinary tract | 7 |
sequence data | 7 |
log reduction | 7 |
chlamydia pneumoniae | 7 |
much lower | 7 |
respiratory activity | 7 |
air movement | 7 |
tuberculosis transmission | 7 |
putative virus | 7 |
recommended practices | 7 |
several days | 7 |
scientificreports www | 7 |
nbd transmission | 7 |
prospective cohort | 7 |
early weaning | 7 |
wearing masks | 7 |
hicpac cdc | 7 |
laboratory confirmed | 7 |
contain infectious | 7 |
polybasic cleavage | 7 |
pandemic potential | 7 |
infectious sars | 7 |
high temperature | 7 |
gov ncidod | 7 |
individual i | 7 |
blood donors | 7 |
contact vaccinia | 7 |
often used | 7 |
data set | 7 |
multiple patients | 7 |
high transmission | 7 |
norovirus outbreak | 7 |
source patient | 7 |
reportable disease | 7 |
relatively high | 7 |
significant risk | 7 |
three different | 7 |
expiratory activities | 7 |
reduce human | 7 |
family ranking | 7 |
infections due | 7 |
perinatal infection | 7 |
case report | 7 |
sensitivity analysis | 7 |
aerodynamic diameter | 7 |
either side | 7 |
emerging viruses | 7 |
cases may | 7 |
human metapneumovirus | 7 |
lumbar puncture | 7 |
riley model | 7 |
infection spread | 7 |
infections may | 7 |
transmission scenarios | 7 |
spatial heterogeneity | 7 |
risk spillover | 7 |
procedures involving | 7 |
adverse effects | 7 |
routine care | 7 |
especially important | 7 |
study design | 7 |
transmission using | 7 |
intervention measures | 7 |
particle aerosols | 7 |
severely ill | 7 |
infant feeding | 7 |
infectious complications | 7 |
chemical disinfectants | 7 |
fatality rates | 7 |
also provides | 7 |
prevention practices | 7 |
randomized controlled | 7 |
vice versa | 7 |
medical mask | 7 |
rapid spread | 7 |
parameter values | 7 |
new studies | 7 |
rates among | 7 |
average economic | 7 |
active surveillance | 7 |
specific recommendations | 7 |
disease epidemiology | 7 |
aerosols generated | 7 |
hospital staff | 7 |
ultraviolet light | 7 |
age groups | 7 |
work area | 7 |
nutritional status | 7 |
infant botulism | 7 |
infection dynamics | 7 |
large respiratory | 7 |
readily available | 7 |
reduce disease | 7 |
gamma distribution | 7 |
mental health | 7 |
examination room | 7 |
breastfeeding mothers | 7 |
descriptive study | 7 |
risk estimate | 7 |
tuberculosis among | 7 |
total cluster | 7 |
waiting areas | 7 |
breastfeeding infant | 7 |
based approach | 7 |
asymptomatic patients | 7 |
klebsiella pneumoniae | 7 |
bacterial transmission | 7 |
illness onset | 7 |
human herpesvirus | 7 |
passenger cars | 7 |
tuberculosis infection | 7 |
salmonella enterica | 7 |
care staff | 7 |
aerosol droplets | 7 |
relatively small | 7 |
size range | 7 |
clinical evidence | 7 |
respiratory infectious | 7 |
sampling studies | 7 |
second order | 7 |
contaminated air | 7 |
epidemic keratoconjunctivitis | 7 |
adverse outcomes | 7 |
potential impact | 7 |
airborne influenza | 7 |
epidemiological evidence | 7 |
host environment | 7 |
may contain | 7 |
observational cohort | 7 |
possible source | 6 |
three cases | 6 |
visitor screening | 6 |
nombre virus | 6 |
cfu ml | 6 |
work environment | 6 |
venous catheter | 6 |
private room | 6 |
nan doi | 6 |
seir model | 6 |
close observation | 6 |
pcr assays | 6 |
prolonged exposure | 6 |
outbreak investigation | 6 |
respiratory aerosols | 6 |
death rate | 6 |
contaminated food | 6 |
viral concentration | 6 |
central nervous | 6 |
risks associated | 6 |
detailed data | 6 |
fmdv transmission | 6 |
environmental reservoirs | 6 |
outbreak simulations | 6 |
transmission chains | 6 |
chest radiograph | 6 |
data suggest | 6 |
spatial variation | 6 |
relative contribution | 6 |
primarily epithelial | 6 |
public authorities | 6 |
airborne routes | 6 |
certain situations | 6 |
infection will | 6 |
contact via | 6 |
healthcare epidemiologist | 6 |
negative impact | 6 |
medical center | 6 |
transmitted diseases | 6 |
may influence | 6 |
fecal matter | 6 |
laboratory testing | 6 |
managed sanitation | 6 |
onto fomites | 6 |
human subjects | 6 |
protect healthcare | 6 |
sin nombre | 6 |
routinely used | 6 |
will vary | 6 |
rural areas | 6 |
short distance | 6 |
simulation result | 6 |
psychological characteristics | 6 |
upper airway | 6 |
level characteristics | 6 |
research work | 6 |
underlying diseases | 6 |
individual differences | 6 |
transmission suggests | 6 |
virus viability | 6 |
surface samples | 6 |
rate may | 6 |
rhinovirus transmission | 6 |
heat source | 6 |
boltzmann method | 6 |
zoonotic disease | 6 |
multiple host | 6 |
inanimate objects | 6 |
two studies | 6 |
recent studies | 6 |
three main | 6 |
infect dis | 6 |
outbreak units | 6 |
potential role | 6 |
school closure | 6 |
transmission appears | 6 |
good program | 6 |
poor growth | 6 |
confined space | 6 |
formula feeding | 6 |
sterile gloves | 6 |
suspension times | 6 |
newborn infant | 6 |
ipc practices | 6 |
contaminated droplets | 6 |
ct value | 6 |
costs associated | 6 |
host infectivity | 6 |
respirator use | 6 |
reduced risk | 6 |
molecular diagnostic | 6 |
evidence supports | 6 |
increased odds | 6 |
facilities may | 6 |
university hospital | 6 |
clinical data | 6 |
coronavirus pneumonia | 6 |
indoor settings | 6 |
input parameters | 6 |
ventive active | 6 |
protect hcws | 6 |
actual transmission | 6 |
er visits | 6 |
exposed susceptible | 6 |
stack effect | 6 |
infectious droplets | 6 |
postoperative infections | 6 |
significant differences | 6 |
another patient | 6 |
treatment facilities | 6 |
inactivate sars | 6 |
fungal infections | 6 |
data available | 6 |
transmission involving | 6 |
lines show | 6 |
highly effective | 6 |
pathogen evolution | 6 |
sars will | 6 |
infectious bronchitis | 6 |
facebook users | 6 |
household water | 6 |
occupied space | 6 |
iatrogenic meningitis | 6 |
response conditions | 6 |
strongly recommended | 6 |
viral infectivity | 6 |
presymptomatic transmission | 6 |
microbial diversity | 6 |
increase transmission | 6 |
measles transmission | 6 |
home infusion | 6 |
strategies may | 6 |
communication messages | 6 |
based method | 6 |
emergency response | 6 |
response rate | 6 |
exposed pigs | 6 |
health officials | 6 |
many instances | 6 |
resistant mycobacterium | 6 |
precautions based | 6 |
using numerical | 6 |
transmission based | 6 |
maternal antibodies | 6 |
infection within | 6 |
od matrix | 6 |
retrospective analysis | 6 |
household size | 6 |
two cases | 6 |
via fomites | 6 |
birds may | 6 |
rsv infection | 6 |
within minutes | 6 |
tertiary care | 6 |
contact network | 6 |
fowl cholera | 6 |
protection clinical | 6 |
size distributions | 6 |
household secondary | 6 |
google scholar | 6 |
study suggested | 6 |
million people | 6 |
joint commission | 6 |
spatial separation | 6 |
hsct patients | 6 |
domestic fowl | 6 |
oncology unit | 6 |
except sweat | 6 |
control recommendations | 6 |
larger average | 6 |
seated within | 6 |
urogenital tract | 6 |
human exhaled | 6 |
adaptive immune | 6 |
studies using | 6 |
ethics approval | 6 |
modeling infectious | 6 |
suboptimal outbreak | 6 |
many susceptible | 6 |
plasmodium falciparum | 6 |
antibody titer | 6 |
antibiotic prophylaxis | 6 |
hiv status | 6 |
developing countries | 6 |
generally less | 6 |
day care | 6 |
diagnostic testing | 6 |
droplet properties | 6 |
organ transplant | 6 |
severe infections | 6 |
different routes | 6 |
onset gbs | 6 |
difficile infection | 6 |
emerging diseases | 6 |
competent hosts | 6 |
tt virus | 6 |
will need | 6 |
livestock viruses | 6 |
antimicrobial susceptibility | 6 |
open access | 6 |
recirculated air | 6 |
asymptomatic carrier | 6 |
public buildings | 6 |
incidence rates | 6 |
person spread | 6 |
environmental determinants | 6 |
live virus | 6 |
increased rates | 6 |
mass masking | 6 |
side effects | 6 |
local interpretations | 6 |
virus dna | 6 |
virus aerosols | 6 |
supplementary information | 6 |
raw data | 6 |
contact routes | 6 |
nvp zdv | 6 |
important means | 6 |
gel electrophoresis | 6 |
per person | 6 |
arthropod vectors | 6 |
simple models | 6 |
disease agents | 6 |
frequently associated | 6 |
table summarizes | 6 |
current study | 6 |
potentially infected | 6 |
infected passengers | 6 |
four times | 6 |
phylogenetic analysis | 6 |
theoretical framework | 6 |
fmd outbreaks | 6 |
first years | 6 |
mathematical modeling | 6 |
possible sars | 6 |
cases associated | 6 |
patients requiring | 6 |
health impact | 6 |
temperate climates | 6 |
small droplets | 6 |
air velocity | 6 |
virus family | 6 |
bayesian model | 6 |
pet birds | 6 |
lower odds | 6 |
epidemic control | 6 |
will cause | 6 |
reservoir host | 6 |
negative results | 6 |
dengue viruses | 6 |
natural infection | 6 |
hgv rna | 6 |
workers involved | 6 |
acute gastroenteritis | 6 |
zoonotic infection | 6 |
retrospective study | 6 |
fungal spores | 6 |
severe cases | 6 |
fatty acids | 6 |
air change | 6 |
clinical outcome | 6 |
generation time | 6 |
exclusively breastfed | 6 |
ventilation air | 6 |
well understood | 6 |
droplets expelled | 6 |
larger particles | 6 |
current ventilation | 6 |
model selection | 6 |
augmented likelihood | 6 |
common source | 6 |
exposed individuals | 6 |
scientific brief | 6 |
shoe covers | 6 |
hospital environment | 6 |
posterior distribution | 6 |
per cent | 6 |
homogeneous mixing | 6 |
simulation model | 6 |
study also | 6 |
days later | 6 |
climatological covariates | 6 |
infant via | 6 |
viruses among | 6 |
ventilation design | 6 |
also provide | 6 |
dry cough | 6 |
teaching hospital | 6 |
breastfed infant | 6 |
asymptomatic student | 6 |
disease among | 6 |
turbulent gas | 6 |
efficiency particulate | 6 |
coping strategies | 6 |
vaccine development | 6 |
influenza aboard | 6 |
prior information | 6 |
medical intensive | 6 |
intact skin | 6 |
infection may | 6 |
infect humans | 6 |
supraglottic airway | 6 |
main text | 6 |
day delay | 6 |
procedures may | 6 |
greatest risk | 6 |
infectious respiratory | 6 |
health doi | 6 |
central line | 6 |
human health | 6 |
least two | 6 |
current evidence | 6 |
viral aerosols | 6 |
skin infections | 6 |
decision making | 6 |
control issues | 6 |
staphylococcal enterotoxin | 6 |
medical devices | 6 |
mortality due | 6 |
using data | 6 |
disinfection strategies | 6 |
will increase | 6 |
mitigation measures | 6 |
successful transmission | 6 |
mildly symptomatic | 6 |
precautions among | 6 |
mass communication | 6 |
credible interval | 6 |
wells evaporation | 6 |
conditioning engineers | 6 |
medical conditions | 6 |
become contaminated | 6 |
rna loads | 6 |
effective measures | 6 |
chinese center | 6 |
will continue | 6 |
chain monte | 6 |
help reduce | 6 |
rhesus monkeys | 6 |
narrative review | 6 |
genetic distance | 6 |
variable transmission | 6 |
animal populations | 6 |
appropriate personal | 6 |
animal host | 6 |
zoonotic diseases | 6 |
virulence management | 6 |
congo hemorrhagic | 6 |
containment measures | 6 |
new coronavirus | 6 |
ffp masks | 6 |
stewardship programs | 6 |
may transmit | 6 |
viral pathogens | 6 |
epidemiologic study | 6 |
mg kg | 6 |
within days | 6 |
cov cases | 6 |
limited data | 6 |
also contribute | 6 |
small proportion | 6 |
early transmission | 6 |
infant zidovudine | 6 |
infect others | 6 |
secondary case | 6 |
predominant route | 6 |
transmission pattern | 6 |
specific antibodies | 6 |
relative transmission | 6 |
personal protection | 6 |
china joint | 6 |
free state | 6 |
pig production | 6 |
concerning breastfeeding | 6 |
dis ease | 6 |
south korean | 6 |
respiratory tracts | 6 |
well documented | 6 |
infectious patient | 6 |
transmission occurring | 6 |
high rate | 6 |
risk communication | 6 |
acquired sars | 6 |
unit patients | 6 |
viral genomic | 6 |
additional risk | 6 |
surgical site | 6 |
percutaneous injury | 6 |
common respiratory | 6 |
local airflow | 6 |
people living | 6 |
another example | 6 |
positive association | 6 |
expiratory events | 6 |
us hospitals | 6 |
high morbidity | 6 |
published reports | 6 |
viral culture | 6 |
based products | 6 |
strong evidence | 6 |
models may | 6 |
droplet borne | 6 |
average daily | 6 |
different sources | 6 |
different epidemic | 6 |
scores allocated | 6 |
examination gloves | 6 |
host cells | 6 |
associated coronavirus | 6 |
rate following | 6 |
onto surfaces | 6 |
weight infants | 6 |
infant may | 6 |
gi tract | 6 |
cause severe | 6 |
flow rates | 6 |
disinfecting surfaces | 6 |
airway devices | 6 |
transmission study | 6 |
among individuals | 6 |
become available | 6 |
affected countries | 6 |
stool samples | 6 |
data types | 6 |
environmental fungi | 6 |
cases reported | 6 |
animal reservoirs | 6 |
occurs infrequently | 6 |
agents transmitted | 6 |
becomes available | 6 |
air supplied | 5 |
school transmission | 5 |
multiple introductions | 5 |
study human | 5 |
disease free | 5 |
different locations | 5 |
disease progression | 5 |
long distance | 5 |
especially hand | 5 |
ebola viruses | 5 |
surgical patients | 5 |
risk populations | 5 |
transmitted primarily | 5 |
invasive aspergillosis | 5 |
two wuhan | 5 |
infected birds | 5 |
care patients | 5 |
sensitivity testing | 5 |
invasive candidiasis | 5 |
significantly reduced | 5 |
donor animal | 5 |
emergency departments | 5 |
chagas disease | 5 |
mediated immunity | 5 |
studies reported | 5 |
molecular typing | 5 |
brief exposure | 5 |
highest risk | 5 |
among people | 5 |
production systems | 5 |
hospital ward | 5 |
may pose | 5 |
immunization schedule | 5 |
statistical analysis | 5 |
specific risk | 5 |
isolation practices | 5 |
host susceptibility | 5 |
several weeks | 5 |
surface cleaning | 5 |
animal reservoir | 5 |
burn center | 5 |
may reach | 5 |
immunodeficiency syndrome | 5 |
results suggest | 5 |
pediatric patient | 5 |
aerosolgenerating procedures | 5 |
vaccination site | 5 |
homemade masks | 5 |
adsorption onto | 5 |
control group | 5 |
aerosolised pathogen | 5 |
healthcare premises | 5 |
short distances | 5 |
appropriate ppe | 5 |
fecal shedding | 5 |
may remain | 5 |
etiologic agent | 5 |
infectious risk | 5 |
susceptible person | 5 |
contaminated environmental | 5 |
mixing ventilation | 5 |
among protected | 5 |
southern china | 5 |
increase disease | 5 |
international flight | 5 |
well established | 5 |
attenuated vaccine | 5 |
efficient transmission | 5 |
data regarding | 5 |
ebola transmission | 5 |
possible role | 5 |
red book | 5 |
help prevent | 5 |
level respirators | 5 |
control intervention | 5 |
exhaled air | 5 |
infectious organisms | 5 |
disease causation | 5 |
male sex | 5 |
recent report | 5 |
using viral | 5 |
possible interventions | 5 |
environmental engineering | 5 |
jurisdictional claims | 5 |
host interactions | 5 |
infected infants | 5 |
epidemiological modelling | 5 |
patient placement | 5 |
via airborne | 5 |
contact isolation | 5 |
clinical situations | 5 |
antiretroviral prophylaxis | 5 |
cerebrospinal fluid | 5 |
via blood | 5 |
surface water | 5 |
genome type | 5 |
hospital transmission | 5 |
specimen collection | 5 |
recommendations concerning | 5 |
water temperature | 5 |
protect health | 5 |
feeding tubes | 5 |
consistent use | 5 |
touch surface | 5 |
vaccination strategies | 5 |
associated methicillin | 5 |
higher mortality | 5 |
adaptive management | 5 |
zoonotic pathogen | 5 |
epithelial transmission | 5 |
based disinfectant | 5 |
roof mounted | 5 |
pathogens standard | 5 |
vary according | 5 |
human rhinovirus | 5 |
tb infection | 5 |
respirators versus | 5 |
open questions | 5 |
also see | 5 |
infectious contact | 5 |
transmission success | 5 |
rna copies | 5 |
several factors | 5 |
require special | 5 |
cross infection | 5 |
presymptomatic sars | 5 |
exact test | 5 |
virus illness | 5 |
air delivery | 5 |
associated transmission | 5 |
increased morbidity | 5 |
novel influenza | 5 |
may seem | 5 |
occupational transmission | 5 |
statistical process | 5 |
infectious curves | 5 |
reduce incidence | 5 |
infant mortality | 5 |
trained model | 5 |
first cases | 5 |
less severe | 5 |
ongoing transmission | 5 |
critical unknowns | 5 |
droplets may | 5 |
one infant | 5 |
infants infected | 5 |
food safety | 5 |
modelling results | 5 |
case series | 5 |
another group | 5 |
candida infections | 5 |
occupationally acquired | 5 |
natural conditions | 5 |
ongoing pandemic | 5 |
lower rate | 5 |
extinction rates | 5 |
rehabilitation centers | 5 |
animal disease | 5 |
hcws exposed | 5 |
epidural anesthesia | 5 |
immune function | 5 |
touched surfaces | 5 |
etiologic agents | 5 |
specific pathogen | 5 |
contaminated water | 5 |
animal hosts | 5 |
effective reproductive | 5 |
collateral effects | 5 |
coli infection | 5 |
detection rate | 5 |
africa ebola | 5 |
hand rub | 5 |
low viral | 5 |
touch surfaces | 5 |
plus infant | 5 |
suspected cases | 5 |
without safely | 5 |
epidemiological investigation | 5 |
national guidelines | 5 |
running water | 5 |
potential importance | 5 |
pathogenic microorganisms | 5 |
first year | 5 |
global distribution | 5 |
several times | 5 |
household settings | 5 |
human expiratory | 5 |
remains unclear | 5 |
important source | 5 |
disease will | 5 |
various surfaces | 5 |
symptoms appear | 5 |
air sample | 5 |
nursing mothers | 5 |
vaccination programs | 5 |
safety climate | 5 |
infiltration ranking | 5 |
systematic analysis | 5 |
hand preparation | 5 |
model using | 5 |
air pressure | 5 |
carrier tests | 5 |
virus evolution | 5 |
biodiversity may | 5 |
infiltrative viruses | 5 |
congo basin | 5 |
little evidence | 5 |
isolation hospitalization | 5 |
paradigm model | 5 |
perform hand | 5 |
patients colonized | 5 |
multiple studies | 5 |
external factors | 5 |
approximation fails | 5 |
mixing parameters | 5 |
bacterial pathogens | 5 |
cleaning practices | 5 |
relatively large | 5 |
community level | 5 |
invasive devices | 5 |
protected health | 5 |
pathogens transmitted | 5 |
factors including | 5 |
primary mode | 5 |
growth rate | 5 |
varicella vaccine | 5 |
pathogen interactions | 5 |
cdc guidelines | 5 |
health management | 5 |
human diseases | 5 |
conditioning systems | 5 |
three infiltration | 5 |
lymphocytic choriomeningitis | 5 |
effective method | 5 |
human monkeypox | 5 |
generating medical | 5 |
passengers seated | 5 |
limited evidence | 5 |
particulate matter | 5 |
incubation time | 5 |
electrostatic forces | 5 |
significantly reduce | 5 |
giardia lamblia | 5 |
nasal secretions | 5 |
rational use | 5 |
air borne | 5 |
airliner cabin | 5 |
infecting agent | 5 |
virulence antigen | 5 |
epidemic parameters | 5 |
longterm care | 5 |
epidemic disease | 5 |
generate aerosols | 5 |
additional protection | 5 |
similar results | 5 |
invasive infection | 5 |
different surfaces | 5 |
symptomatic index | 5 |
spearman correlation | 5 |
maternal illness | 5 |
immune status | 5 |
first positive | 5 |
springer nature | 5 |
korean outbreak | 5 |
routine cleaning | 5 |
ventive windhive | 5 |
process control | 5 |
temporal component | 5 |
mixing patterns | 5 |
copies ml | 5 |
genetic material | 5 |
unintended consequences | 5 |
animal viruses | 5 |
fibrosis patients | 5 |
comparative analysis | 5 |
immunity level | 5 |
via aerosol | 5 |
currently available | 5 |
safe work | 5 |
particular disease | 5 |
emerging zoonoses | 5 |
resistant tuberculosis | 5 |
milder disease | 5 |
described earlier | 5 |
although many | 5 |
patients receiving | 5 |
important component | 5 |
common vehicle | 5 |
various sizes | 5 |
input tensor | 5 |
mortality may | 5 |
study ii | 5 |
vancomycin resistance | 5 |
transplacental spread | 5 |
kangaroo care | 5 |
peripheral blood | 5 |
producing klebsiella | 5 |
infectious passenger | 5 |
toxic shock | 5 |
parameter estimates | 5 |
credible intervals | 5 |
little information | 5 |
clinical presentation | 5 |
construction dust | 5 |
spillover control | 5 |
outbreak will | 5 |
control implications | 5 |
disease system | 5 |
designated hospital | 5 |
increased susceptibility | 5 |
score low | 5 |
information may | 5 |
risk based | 5 |
wildlife diseases | 5 |
collaborative study | 5 |
airborne infections | 5 |
classic example | 5 |
commercially available | 5 |
marrow transplant | 5 |
important organisms | 5 |
york city | 5 |
surrounding areas | 5 |
porous media | 5 |
onset disease | 5 |
transmission event | 5 |
domestic animals | 5 |
identify patients | 5 |
administrative controls | 5 |
control nurse | 5 |
scoping review | 5 |
biological weapon | 5 |
known outbreak | 5 |
probable sars | 5 |
transmission prevention | 5 |
emission rates | 5 |
modeling approach | 5 |
also necessary | 5 |
aseptic technique | 5 |
risk areas | 5 |
serratia marcescens | 5 |
usually occurs | 5 |
young birds | 5 |
family member | 5 |
yolk sac | 5 |
human papillomavirus | 5 |
transmission due | 5 |
gas mask | 5 |
sars epidemic | 5 |
candida albicans | 5 |
spread around | 5 |
clinical samples | 5 |
regular testing | 5 |
extensive environmental | 5 |
remain asymptomatic | 5 |
prevention act | 5 |
infected cells | 5 |
mild disease | 5 |
evolutionary dynamics | 5 |
well characterized | 5 |
analysis using | 5 |
control strategy | 5 |
high schools | 5 |
candida spp | 5 |
burkholderia cepacia | 5 |
odds ratios | 5 |
healthcare facility | 5 |
cluster randomized | 5 |
physical examination | 5 |
important information | 5 |
tumor virus | 5 |
community settings | 5 |
mother may | 5 |
available concerning | 5 |
frequently touched | 5 |
granger causality | 5 |
among hospitalized | 5 |
transmission following | 5 |
airborne versus | 5 |
postnatal exposure | 5 |
particular interest | 5 |
banked breast | 5 |
model fitting | 5 |
factors may | 5 |
urgent need | 5 |
high proportion | 5 |
common cause | 5 |
contact per | 5 |
also known | 5 |
service guidelines | 5 |
flow regime | 5 |
turbulent flow | 5 |
multivariate analysis | 5 |
acquired immunodeficiency | 5 |
antibody responses | 5 |
likely due | 5 |
great britain | 5 |
surface area | 5 |